BMC Neuroscience 2012, 13:33 doi:10.1186/1471-2202-13-33
Kerry Hunter and Christian Holscher
OPEN ACCESS, FULL TEXT PDF
"Conclusions:
Our results suggest that these novel incretin analogues cross the BBB and show physiological activity and neurogenesis in the brain, which may be of use as a treatment of neurodegenerative diseases."
Subscribe to:
Posts (Atom)
